Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase to Prevent Perineal Trauma in Nulliparous Vaginal Delivery
KCT0002855Phase 3Completed
- Sponsor
- BMI
- Start
- Jan 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in perineal injury comparing Hyaluronidase with Placebo (2 arms). Primary endpoints: Perineal trauma incidence and Safety of hyaluronidase. Started Jan 2016; status: completed.
02
Drugs
hyaluronidase
03
Conditions
perineal injury
Beyond the preview
Go deeper on KCT0002855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002855.